panitumumab
amgen,takeda
['rectal', 'paradigm', 'colorectal', 'takedaoncology', 'amgen', 'takeda', '$amgn']
amgen and announced today that key results from the phase 3 paradigm trial in patients with ras wild type metastatic colorectal cancer will be highlighted during the #asco22 plenary session. $amgn
Patients. They're why we develop and manufacture innovative human therapeutics to treat serious diseases. Community Guidelines: https://t.co/OL3aHKGSfd